Amy S Ciner, MD | |
1621 Eastchester Rd, Bronx, NY 10461-2604 | |
(718) 405-8040 | |
Not Available |
Full Name | Amy S Ciner |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 1621 Eastchester Rd, Bronx, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023053519 | NPI | - | NPPES |
03025183 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 237664 (New York) | Primary |
Entity Name | Montefiore Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
The need for improved monitoring of neurotrauma patients has resulted in the development of a prototype of a novel, multitasking "lab on a tube" at the University of Cincinnati (UC).
While Congress debates whether health care reform would control health care costs, Leapfrog's purchaser members point to 45 hospitals that lead through example - delivering the best quality care in the nation while attaining the highest levels of efficiency.
Firefighters are more likely to be injured while exercising than while putting out fires, suggests research published online in Injury Prevention.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 8 days ago
Entity Name | Boston Children's Health Physicians Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467454967 PECOS PAC ID: 8325937014 Enrollment ID: O20040311000864 |
News Archive
The need for improved monitoring of neurotrauma patients has resulted in the development of a prototype of a novel, multitasking "lab on a tube" at the University of Cincinnati (UC).
While Congress debates whether health care reform would control health care costs, Leapfrog's purchaser members point to 45 hospitals that lead through example - delivering the best quality care in the nation while attaining the highest levels of efficiency.
Firefighters are more likely to be injured while exercising than while putting out fires, suggests research published online in Injury Prevention.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Amy S Ciner, MD 111 E 210th St, Bronx, NY 10467-2401 Ph: () - | Amy S Ciner, MD 1621 Eastchester Rd, Bronx, NY 10461-2604 Ph: (718) 405-8040 |
News Archive
The need for improved monitoring of neurotrauma patients has resulted in the development of a prototype of a novel, multitasking "lab on a tube" at the University of Cincinnati (UC).
While Congress debates whether health care reform would control health care costs, Leapfrog's purchaser members point to 45 hospitals that lead through example - delivering the best quality care in the nation while attaining the highest levels of efficiency.
Firefighters are more likely to be injured while exercising than while putting out fires, suggests research published online in Injury Prevention.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 8 days ago
Dr. Madhu Sharma, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Montefiore Medical Center, Bronx, NY 10467 Phone: 718-741-2538 | |
Dr. Amanda Mcnear Jacobs, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Department Of Pediatrics, Bronx, NY 10467 Phone: 718-920-2306 | |
Colleen Gerrity, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4487 3rd Ave, Bronx, NY 10457 Phone: 718-960-6497 Fax: 718-960-9138 | |
Mr. Rodolfo Comuyog Uy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Nereid Ave, Bronx, NY 10466 Phone: 718-994-6755 Fax: 718-994-3032 | |
Dr. Daniela Levanon, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1400 Pelham Pkwy S, Bronx, NY 10461 Phone: 718-918-3060 Fax: 718-918-4469 | |
Marguerite M Mayers, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Mmc - Family Care Center, 3444 Kossuth Avenue, 2nd Fl., Bronx, NY 10467 Phone: 718-920-5271 Fax: 718-652-5707 | |
Merryl A Schechtman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1225 Morris Park Ave, Bronx, NY 10461 Phone: 718-430-3922 Fax: 718-839-7229 |